Research Topics
| F X BoschSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk populationM Paz Cañadas
Departament de Biologia Molecular, General Lab, Barcelona, Spain
J Clin Microbiol 42:1330-2. 2004..HPV was found in 43.6% of the women, and its prevalence at genital sites was similar. Prevalence was highest among women aged 20 years or younger but declined thereafter in specimens from all anogenital sites...
HPV and cervical cancer: screening or vaccination?F X Bosch
Cancer Epidemiology and Registration Unit, IDIBELL, Institut Catala d Oncologia, L Hospitalet del Llobregat, Barcelona, Spain
Br J Cancer 98:15-21. 2008..Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition...
Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in SpainLuis M Puig-Tintore
Gynecologic Oncology, Hospital Clinic, University of Barcelona, Catalonia, Spain
J Low Genit Tract Dis 12:82-9. 2008..To quantify the coverage and monitor the factors associated with opportunistic cervical cytological screening in Spain...
Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countriesK S Louie
Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Hospitalet del Llobregat Barcelona, Barcelona, Spain
Br J Cancer 100:1191-7. 2009..These data confirm AFSI and AFB as risk factors for ICC in eight developing countries, but any independent effects of these two events could not be distinguished...
Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseasesF Xavier Bosch
Cancer Epidemiology Research Program, Institut Català d Oncologia Catalan Institute of Oncology, L Hospitalet de Llobregat, Barcelona, Spain
Vaccine 30:F1-11. 2012..This article forms part of a special supplement entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012...
Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, SpainRaquel Ibanez
Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Av, Gran Via, 199 203L Hospitalet de Llobregat, 08907 Barcelona, Spain
BMC Infect Dis 12:25. 2012..We evaluated the implementation of the protocol and the prediction of HPV testing as a triage tool for cervical intraepithelial lesions grade two or worse (CIN2+) in women with a cytological diagnosis of ASC-US...
Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear ArrayJose M Godínez
Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL, Catalan Institute of Oncology ICO, Gran Via 199 203, L Hospitalet de Llobregat 08907, Barcelona, Spain
Infect Agent Cancer 6:23. 2011..abstract:..
Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in SpainXavier Castellsague
Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL Institut Català d Oncologia ICO, Hospitalet de Llobregat, Barcelona, Spain
BMC Infect Dis 9:74. 2009..Studies on HPV infection in pregnant women and HPV transmission to the child have yielded inconsistent results...
Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from ItalyLuciano Mariani
Regina Elena National Cancer Institute, Dept Gynecologic Oncology, Roma, Italy
BMC Cancer 10:259. 2010..Human papillomavirus (HPV) infection is now well-established as a necessary cause of invasive cervical cancer (ICC) development. Only a few studies on HPV prevalence and type-specific distribution in ICC have been conducted in Italy...
Preface. The field of cervical cancer preventionF Xavier Bosch
Epidemiology and Cancer Registry Unit, IDIBELL, , Avenida Gran Via s/n, L'Hospitalet de Llobregat, Barcelona, Spain
Vaccine 24:S3/v-vi. 2006
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasiaF Xavier Bosch
Cancer Epidemiology Research Program CERP, Institut Català d Oncologia Catalan Institute of Oncology ICO, L Hospitalet de Llobregat Barcelona, Spain
Vaccine 26:K1-16. 2008....
[Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners]S de Sanjose
Servicio de Epidemiología y Registro del Cáncer, Institut Catala d Oncologia, Barcelona
Med Clin (Barc) 115:81-4. 2000..The study was designed to estimate the prevalence of HPV infection and the related risk of cervical cancer among imprisoned women...
Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conferenceF X Bosch
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
J Clin Pathol 54:163-75. 2001..This leader summarises the highlights presented at the conference (the full text of the abstracts and lectures can be found at www.hpv2000.com). Relevant material in Spanish can be found at www.aepcc.org...
Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in IndiaM Diaz
Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Programme, Catalan Institute of Oncology ICO, Av Gran Via, s n km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Br J Cancer 99:230-8. 2008....
Human papillomavirus prevalence and type distribution in penile carcinomaC Miralles-Guri
Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, L Hospitalet de Ll, Barcelona, Spain
J Clin Pathol 62:870-8. 2009..HPV prevalence in penile tumours is reported to be associated to a variety of morphological changes. Its determination will provide a better estimate for HPV related cancer burden and its preventable fraction...
Epidemiology of primary liver cancerF X Bosch
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
Semin Liver Dis 19:271-85. 1999....
Epidemiology of liver cancer in EuropeF X Bosch
L Hospitalet de Llobregat, Barcelona, Spain
Can J Gastroenterol 14:621-30. 2000....
Differential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58J M Godínez
Unit of Infections and Cancer, Cancer Epidemiology Research Program, Bellvitge Institute of Biomedical Research IDIBELL, Catalan Institute of Oncology ICO, Barcelona, Spain
Infect Genet Evol 13:96-104. 2013..The aim of the present work was to analyze the presence of HPV33, HPV45 and HPV58 variants in cases of cervical cancer...
The causal relation between human papillomavirus and cervical cancerF X Bosch
Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, Gran Via Km 2 7 s n 08907 L Hospitalet de Llobregat, 08907 Barcelona, Spain
J Clin Pathol 55:244-65. 2002..It is the right time for medical societies and public health regulators to consider this evidence and to define its preventive and clinical implications. A comprehensive review of key studies and results is presented...
HPV vaccines and cervical cancerF X Bosch
Cancer Epidemiology Research Program (CERP, IDIBELL, , L'Hospitalet del Llobregat, Barcelona, Spain
Ann Oncol 19:v48-51. 2008
Risk factors of invasive cervical cancer in MaliSine Bayo
Institut National de Recherche en Sante Publique, Bamako, Mali
Int J Epidemiol 31:202-9. 2002..Cervical cancer is the most common cancer in women in Mali and the second commonest cause of cancer mortality...
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and preventionXavier Castellsague
Institut d Investigacio Biomedica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d Oncologia L Hospitalet de Llobregat, Barcelona, Spain
J Natl Cancer Inst 98:303-15. 2006..The extent to which human papillomavirus (HPV) infection and cofactors may explain this differential trend is unclear...
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisSilvia de Sanjose
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Barcelona, Spain
Lancet Infect Dis 7:453-9. 2007..The HPV types most commonly detected are similar to those most commonly described in pre-neoplastic and cancer cases, although the relative contribution of HPV16 and HPV18 is substantially lower in cytologically normal women...
The epidemiology of human papillomavirus infection and cervical cancerF Xavier Bosch
Institut Catala d Oncologia, Epidemiology and Cancer Registration Unit, E 08907 L Hospitalet de Llobregat, Barcelona, Spain
Dis Markers 23:213-27. 2007..Women exposed to the Human Immunodeficiency Virus (HIV) are at high risk for HPV infection, HPV DNA persistency and progression of HPV lesions to cervical cancer...
Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for preventionXavier Castellsague
IDIBELL, Institut Català d Oncologia ICO, L Hospitalet de Llobregat, Barcelona, Spain
Int J Cancer 122:1901-4. 2008..The introduction of an efficacious HPV 16/18 vaccine could potentially prevent the occurrence of 72% of cervical cancer cases and up to 81% of the cases if full cross-protection against HPVs 31 and 45 is assumed...
Is viral status needed before vaccination?Thomas C Wright
Department of Pathology, Columbia University, Room 16 404, P and S Building, 630 West 168th Street, New York, NY, United States
Vaccine 26:A12-5. 2008..The increase in cost and the other barriers afforded by a prior to vaccination test requirement would result in a lower coverage, the key indicator of a successful vaccination program...
Against which human papillomavirus types shall we vaccinate and screen? The international perspectiveNubia Munoz
International Agency for Research on Cancer, Lyon, France
Int J Cancer 111:278-85. 2004..The impact of modifying the number of types in the screening cocktail tests would be small and probably irrelevant for screening programs...
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccineSue J Goldie
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
J Natl Cancer Inst 96:604-15. 2004..We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 vaccine in a population with an organized cervical cancer screening program...
Cervical cancer control, priorities and new directionsJoseph Monsonego
EUROGIN, Paris, France
Int J Cancer 108:329-33. 2004..We report the conclusions of the Experts' Meeting at the EUROGIN 2003 conference...
Cervical human papillomavirus infection in the female population in Barcelona, SpainSilvia de Sanjose
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Gran Via km 2 7 E 08907 L Hospitalet de Llobregat, Barcelona, Spain
Sex Transm Dis 30:788-93. 2003..Human papillomavirus (HPV) is a major cause of invasive cervical cancer. Identification of HPV determinants might allow for targeting of high-risk groups for cervical cancer...
Epidemiologic classification of human papillomavirus types associated with cervical cancerNubia Munoz
International Agency for Research on Cancer, Lyons, France
N Engl J Med 348:518-27. 2003..Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but the risk associated with the various HPV types has not been adequately assessed...
Environmental co-factors in HPV carcinogenesisXavier Castellsague
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Gran Vias n km 2, 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
Virus Res 89:191-9. 2002....
The viral etiology of cervical cancerF Xavier Bosch
Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, Hospital Duran i Reynals, Gran Via km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Virus Res 89:183-90. 2002..This is a subjective evaluation that could be guided by a careful description of the most relevant studies and findings...
Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancerJennifer S Smith
Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
J Natl Cancer Inst 94:1604-13. 2002..We performed a pooled analysis of seven case-control studies to examine the effect of one possible HPV cofactor, herpes simplex virus-2 (HSV-2) infection, in the etiology of invasive cervical cancer...
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partnersXavier Castellsague
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Hospitalet de Llobregat, Barcelona, Spain
N Engl J Med 346:1105-12. 2002..It is uncertain whether male circumcision reduces the risks of penile human papillomavirus (HPV) infection in the man and of cervical cancer in his female partner...
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control studyNubia Munoz
Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
Lancet 359:1093-101. 2002..To assess the role of reproductive factors in the progression from HPV infection to cancer, we did a pooled analysis including only HPV-positive women...
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control studyVictor Moreno
Epidemiology and Cancer Registry Service, Catalan Institute of Oncology, Hospital Duran i Reynals, L Hospitalet de Llobregat, Barcelona, Spain
Lancet 359:1085-92. 2002..We aimed to assess how use of oral contraceptives affected risk of cervical cancer in women who tested positive for HPV DNA...
Human papillomavirus in cervical cancerF Xavier Bosch
Servei dEpidemiologia i Registre del Càncer, Institut Català dOncologia, Av Gran Via, s n km 2 7, 08907 LHospitalet de Llobregat, Barcelona, Spain
Curr Oncol Rep 4:175-83. 2002....
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter studyRolando Herrero
International Agency for Research on Cancer, Lyon, France. rherrero@ amnet.co.cr
J Natl Cancer Inst 95:1772-83. 2003..The most common HPV type in genital cancers (HPV16) was also the most common in these tumors. The mechanism of transmission of HPV to the oral cavity warrants further investigation...
Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the PhilippinesJennifer S Smith
International Agency for Research on Cancer, F 69372 Lyon Cedex 08, France
J Infect Dis 185:324-31. 2002..C. trachomatis infection was found to be a possible cofactor of HPV in the etiology of squamous cervical cancer, and its effect may be mediated by chronic inflammation...
Epidemiology of human papillomavirus infections: new options for cervical cancer preventionF Xavier Bosch
Epidemiology and Cancer Registration Unit SERC, Catalan Institute of Oncology ICO, Hospital Duran i Reynals, Avenida Gran Via, s n km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Salud Publica Mex 45:S326-39. 2003..Time is ripe for exploring in depth the clinical implications of current achievements and to devise novel strategies for the prevention of cervical cancer. This paper is available too at: http://www.insp.mx/salud/index.html...
Variations in the age-specific curves of human papillomavirus prevalence in women worldwideSilvia Franceschi
International Agency for Research on Cancer, Lyon, France
Int J Cancer 119:2677-84. 2006..These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences...
Primary liver cancer: worldwide incidence and trendsF Xavier Bosch
Epidemiology and Cancer Registration Unit, IDIBELL Institut Català d Oncologia, Avda Gran Via s n, Km 2 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
Gastroenterology 127:S5-S16. 2004..Primary liver cancer is the first human cancer largely amenable to prevention using hepatitis B virus vaccines and screening of blood and blood products for hepatitis B and C viruses...
Epidemiology of hepatocellular carcinomaF Xavier Bosch
Epidemiology and Cancer Registration Unit, IDIBELL, Institut Catala d Oncologia, Avda Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Clin Liver Dis 9:191-211, v. 2005..Primary liver cancer is the first human cancer largely amenable to prevention using hepatitis B virus vaccines and screening of blood and blood products for hepatitis B and C viruses...
Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in SpainSilvia de Sanjose
Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
Int J Cancer 98:155-8. 2002..All PBMC samples were negative. These results suggest that in low-risk countries for KSHV, oral shedding and heterosexual contacts are potential pathways for KSHV transmission...
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16Itzel E Calleja-Macias
Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697-3900, USA
J Virol 79:13630-40. 2005..Some had one, two, or three amino acid substitutions in these regions, which might indicate biological and pathogenic diversity between the variants of each HPV type...
Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18Jose C Prado
Ludwig Institute for Cancer Research, Sao Paulo, Brazil
Virology 340:95-104. 2005....
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph ConsortiumNathaniel Rothman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Lancet Oncol 7:27-38. 2006..We aimed to test this hypothesis using previously unpublished data from eight European, Canadian, and US case-control studies of the International Lymphoma Epidemiology Consortium (InterLymph)...
Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control studyJennifer S Smith
International Agency for Research on Cancer, Lyon, France
Int J Cancer 111:431-9. 2004..0; 95% CI = 0.53-1.9) in HPV DNA-positive women. An association of C. trachomatis with squamous cell ICC was found among all cases and control women with or without adjustment for HPV...
Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancerEduardo L Franco
Division of Cancer Epidemiology, Departments of Oncology and Epidemiology and Biostatistics, McGill University, 546 Pine Avenue West, Montreal, Quebec, Canada
Vaccine 24:S3/242-9. 2006..The field of HPV and cervical cancer prevention has never been so multi-disciplinary. A new era has begun and the challenges are many...
Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based studySilvia de Sanjose
Institut Catala d Oncologia, Hospitalet de LL, Barcelona, Spain
Int J Cancer 106:588-93. 2003..The contribution of these genes to early-onset breast cancer is likely to be even higher given that certain UV cases might be disease-associated...
Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional studySilvia Franceschi
International Agency for Research on Cancer, Lyon, France
Sex Transm Dis 34:563-9. 2007..Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas...
HPV and circumcision: a biased, inaccurate and misleading meta-analysisXavier Castellsague
J Infect 55:91-3; author reply 93-6. 2007
The male role in cervical cancerXavier Castellsague
Institut Catala d Oncologia, Servel d Epidemiologia I Registre del Càncer, Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
Salud Publica Mex 45:S345-53. 2003..More research is needed to better understand the natural history and epidemiology of HPV infections in men. This paper is available too at: http://www.insp.mx/salud/index.html...
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialJorma Paavonen
University of Helsinki, Department of Obstetrics and Gynaecology, Helsinki, Finland
Lancet 369:2161-70. 2007....
Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control studyMartyn Plummer
Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372 Lyon, France
Cancer Causes Control 14:805-14. 2003..This analysis is part of a series of analyses of cofactors of HPV in the aetiology of cervical cancer...
Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirionsMaxime J J Fleury
INSERM U618, Tours, France
Clin Vaccine Immunol 15:172-5. 2008..Neutralizing antibodies were detected in 78% of subjects with a positive enzyme-linked immunosorbent assay...
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international expertsThomas C Wright
Department of Pathology, Columbia University, 630 W 168th Street, NY 10032, USA
Vaccine 24:S3/251-61. 2006..In this summary, we summarize the opinions of this expert group on how these advances can be introduced to provide the maximum benefit to women and to reduce the global burden of cervical cancer...
Can screening for cervical cancer be improved, especially in developing countries?Anthony B Miller
Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany
Int J Cancer 107:337-40. 2003
[Assessment of HPV detection assays for use in cervical cancer screening programs]M Paz Cañadas
Departamento de Biologia Molecular, Laboratorio de Análisis, General Lab, Barcelona, Espana
Salud Publica Mex 48:373-8. 2006..The different techniques for detection of this cancer need to be contrasted and validated for use in population screening...
